Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobind...

FDA Drug Recall #D-498-2013 — Class III — April 9, 2013

Recall Summary

Recall Number D-498-2013
Classification Class III — Low risk
Date Initiated April 9, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Aurobindo Pharma USA Inc
Location Plainsboro, NJ
Product Type Drugs
Quantity 1776 bottles

Product Description

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India

Reason for Recall

Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label

Distribution Pattern

Nationwide

Lot / Code Information

Lot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13

Other Recalls from Aurobindo Pharma USA Inc

Recall # Classification Product Date
D-0471-2025 Class II Acetaminophen Tablets, 325 mg, 100-count bottle... May 22, 2025
D-0149-2025 Class II Nebivolol Tablets, 2.5. mg, 30-count bottles, R... Dec 6, 2024
D-0078-2025 Class II Cinacalcet Tablets, 60mg, packaged in: a) 30-co... Nov 7, 2024
D-0077-2025 Class II Cinacalcet Tablets, 30 mg, packaged in: a) 30-c... Nov 7, 2024
D-0079-2025 Class II Cinacalcet Tablets, 90 mg, packaged in: a) 30-c... Nov 7, 2024

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.